Loading...
XJPX3088
Market cap5.66bUSD
Dec 24, Last price  
2,204.00JPY
1D
-0.05%
1Q
-4.15%
Jan 2017
-23.47%
IPO
98.56%
Name

MatsukiyoCocokara & Co

Chart & Performance

D1W1MN
XJPX:3088 chart
P/E
16.99
P/S
0.87
EPS
129.71
Div Yield, %
1.49%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
12.16%
Revenues
1.02t
+7.49%
305,312,000,000312,982,000,000345,460,000,000390,934,000,000392,268,000,000393,007,000,000428,184,000,000434,597,000,000456,311,000,000495,385,000,000485,512,000,000536,052,000,000535,133,000,000558,879,000,000575,991,000,000590,593,000,000556,907,000,000729,969,000,000951,247,000,0001,022,531,000,000
Net income
52.35b
+29.11%
5,512,000,0002,309,000,0004,133,000,0006,801,000,0007,728,000,0007,281,000,0007,291,000,0009,955,000,00011,270,000,00013,355,000,00011,619,000,00017,853,000,00020,119,000,00022,755,000,00025,035,000,00026,176,000,00021,602,000,00034,377,000,00040,545,000,00052,347,000,000
CFO
63.51b
-0.87%
8,425,000,0005,758,000,00016,964,000,00018,313,000,0009,423,000,0007,555,000,00011,266,000,00016,246,000,00019,175,000,00026,216,000,0009,010,000,00031,075,000,00023,722,000,00027,938,000,00021,897,000,00024,764,000,00025,875,000,00039,812,000,00064,061,000,00063,506,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 12, 2025

Profile

MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
URL
https://www.matsumotokiyoshi-hd.co.jp/
IPO date
Oct 01, 2007
Employees
13,657
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,022,531,000
7.49%
951,247,000
30.31%
729,969,000
31.08%
Cost of revenue
924,573,000
624,058,000
491,360,000
Unusual Expense (Income)
NOPBT
97,958,000
327,189,000
238,609,000
NOPBT Margin
9.58%
34.40%
32.69%
Operating Taxes
28,630,000
24,141,000
15,016,000
Tax Rate
29.23%
7.38%
6.29%
NOPAT
69,328,000
303,048,000
223,593,000
Net income
52,347,000
29.11%
40,545,000
17.94%
34,377,000
59.14%
Dividends
(13,252,000)
(10,580,000)
(8,272,000)
Dividend yield
1.30%
0.36%
0.46%
Proceeds from repurchase of equity
(3,679,000)
(11,698,000)
(11,644,000)
BB yield
0.36%
0.40%
0.64%
Debt
Debt current
20,075,000
2,114,000
2,640,000
Long-term debt
1,881,000
21,315,000
23,916,000
Deferred revenue
17,857,000
16,649,000
Other long-term liabilities
20,654,000
3,334,000
3,472,000
Net debt
(120,104,000)
(167,346,000)
(134,572,000)
Cash flow
Cash from operating activities
63,506,000
64,061,000
39,812,000
CAPEX
(21,965,000)
(16,746,000)
(10,966,000)
Cash from investing activities
(22,760,000)
(19,669,000)
(15,485,000)
Cash from financing activities
(18,273,000)
(23,734,000)
(20,337,000)
FCF
99,000,000
306,667,000
130,346,000
Balance
Cash
117,720,000
95,224,000
74,519,000
Long term investments
24,340,000
95,551,000
86,609,000
Excess cash
90,933,450
143,212,650
124,629,550
Stockholders' equity
330,423,000
766,767,000
722,655,000
Invested Capital
465,558,550
367,820,350
371,213,450
ROIC
16.64%
82.01%
84.33%
ROCE
17.33%
62.60%
47.21%
EV
Common stock shares outstanding
417,858
422,376
417,137
Price
2,439.50
-65.20%
7,010.00
61.71%
4,335.00
-12.07%
Market cap
1,019,364,591
-65.57%
2,960,858,718
63.74%
1,808,288,587
-12.07%
EV
899,707,591
3,265,693,718
2,131,552,587
EBITDA
120,325,000
348,029,000
253,470,000
EV/EBITDA
7.48
9.38
8.41
Interest
57,000
53,000
60,000
Interest/NOPBT
0.06%
0.02%
0.03%